Genomics Explained

MTHFR C677T: What It Actually Means

A clear, evidence-based guide to the most talked-about gene in nutrition genomics — what the MTHFR gene does, how the C677T variant affects your folate metabolism, and what to do about it.

What Is the MTHFR Gene?

MTHFR stands for methylenetetrahydrofolate reductase. It is a gene that encodes an enzyme of the same name — one that plays a central role in how your body processes folate (vitamin B9). Every cell in your body needs folate to make DNA, repair DNA, and carry out a process called methylation, which controls everything from gene expression to neurotransmitter production.

Specifically, the MTHFR enzyme converts a form of folate called 5,10-methylenetetrahydrofolate into 5-methyltetrahydrofolate (5-MTHF), which is the biologically active form your body actually uses. This active folate is critical for converting the amino acid homocysteine back into methionine, which your body then uses to produce S-adenosylmethionine (SAMe) — the universal methyl donor involved in over 200 biochemical reactions.

When the MTHFR enzyme works less efficiently, this entire chain is affected: less active folate is produced, homocysteine can accumulate, and methylation capacity may be reduced. This is where the genetic variants come in.

C677T and A1298C: The Two Main MTHFR Variants

There are two well-studied variants (also called polymorphisms) in the MTHFR gene that affect enzyme function:

C677T (rs1801133)

Located at position 677 in the gene. The “C” (cytosine) is swapped for a “T” (thymine). This single nucleotide change causes an alanine-to-valine substitution in the enzyme protein, making it thermolabile — less stable at body temperature and therefore less efficient. C677T is the more clinically significant of the two variants and the one most commonly discussed.

A1298C (rs1801131)

Located at position 1298. The “A” (adenine) is swapped for a “C” (cytosine). This causes a glutamate-to-alanine substitution in the regulatory domain of the enzyme. A1298C has a milder effect on enzyme activity compared to C677T and is less strongly associated with elevated homocysteine on its own. However, being compound heterozygous (carrying one copy of each variant) can have a meaningful combined effect.

Understanding Your Genotype: CC, CT, and TT

You inherit two copies of the MTHFR gene — one from each parent. For the C677T variant, the three possible genotypes and their effects on enzyme activity are:

CC
Normal
100% enzyme activity

Both copies carry the common C allele. The MTHFR enzyme functions at full capacity. This is the most common genotype in most populations.

CT
Heterozygous
~65-70% enzyme activity

One copy carries the T variant. Enzyme activity is reduced by approximately 30-35%. This is very common — roughly 30-40% of many populations carry this genotype.

TT
Homozygous
~25-30% enzyme activity

Both copies carry the T variant. Enzyme activity is reduced by approximately 60-70%. Found in about 10-15% of European-descent populations, and higher in some Hispanic and Italian populations.

Key nuance: These percentages describe enzyme activity in laboratory conditions. Real-world impact depends on your overall folate intake, B12 status, and other genetic and lifestyle factors. A TT individual with excellent folate intake may have perfectly normal homocysteine levels and no clinical issues whatsoever.

The Real Impact: Folate, Homocysteine, and Methylation

The practical consequences of reduced MTHFR enzyme activity come down to three interconnected areas:

1. Reduced Active Folate Production

With lower enzyme efficiency, your body converts less dietary folate into its active 5-MTHF form. This does not mean you are folate deficient — it means you may need more folate from dietary sources, or may benefit from taking the already-active form (methylfolate) rather than standard folic acid, which requires MTHFR to convert it.

2. Elevated Homocysteine

Because active folate is needed to recycle homocysteine back into methionine, less 5-MTHF can mean homocysteine accumulates in the blood. Elevated homocysteine (hyperhomocysteinemia) is an independent risk factor for cardiovascular disease, stroke, and blood clots. The TT genotype is most strongly associated with elevated homocysteine, particularly when folate intake is low.

3. Downstream Methylation Effects

Methylation is involved in neurotransmitter synthesis (serotonin, dopamine, norepinephrine), DNA repair, detoxification, and gene regulation. While the direct clinical impact of reduced methylation capacity from MTHFR variants alone is still an active area of research, the pathway is well established biochemically. This is one reason MTHFR status is discussed in the context of mental health, though the direct causal links are more complex than some popular sources suggest.

Common Misconceptions About MTHFR

MTHFR is one of the most misunderstood topics in consumer genomics. Here is what the evidence actually says:

Myth: MTHFR C677T is a rare, dangerous mutation

Reality: It is one of the most common genetic polymorphisms in the human population. Approximately 40% of people worldwide carry at least one T allele. In some populations (Southern European, Hispanic, East Asian), the frequency is even higher. Calling it a "mutation" is technically misleading — it is a normal variant that has persisted in human populations for thousands of years. The more accurate term is polymorphism or variant.

Myth: Having an MTHFR variant means you cannot process folic acid at all

Reality: Even homozygous TT individuals retain 25-30% of normal enzyme activity. The enzyme still works — just less efficiently. Additionally, there are other metabolic pathways that contribute to folate metabolism. The issue is reduced capacity, not total inability.

Myth: MTHFR variants cause dozens of diseases directly

Reality: Some online sources attribute everything from chronic fatigue to autism to MTHFR variants. The well-established clinical associations are primarily with elevated homocysteine (and therefore cardiovascular risk) and neural tube defect risk during pregnancy when folate is insufficient. Many other claimed associations lack robust evidence or involve complex multi-gene interactions.

Myth: You need expensive genetic supplements if you have an MTHFR variant

Reality: For most carriers, eating a folate-rich diet and, if needed, taking an affordable methylfolate supplement is sufficient. There is no need for elaborate supplement protocols. A simple blood test for homocysteine levels can tell you if your current approach is working.

MTHFR in Context: Pregnancy, Mental Health, and Cardiovascular Risk

Pregnancy and Neural Tube Defects

This is the most well-established clinical context for MTHFR. Folate is critical during early pregnancy for neural tube closure, which occurs in the first 28 days — often before a woman even knows she is pregnant. Women who are homozygous TT and have low folate intake have a higher risk of having a child with a neural tube defect (such as spina bifida). This is exactly why prenatal folate supplementation is universally recommended. Women who know they carry the TT genotype may benefit from discussing methylfolate supplementation with their healthcare provider, as it bypasses the need for MTHFR conversion entirely.

Mental Health

Because the folate-methylation pathway is involved in producing neurotransmitters like serotonin and dopamine, researchers have investigated whether MTHFR variants contribute to depression and anxiety. Some meta-analyses have found modest associations between the TT genotype and increased depression risk, but the effect size is small and heavily influenced by environmental factors like diet and overall B-vitamin status. MTHFR status alone is not diagnostic or predictive for mental health conditions, but it may be one piece of a larger puzzle, particularly for individuals who do not respond well to standard treatments and have confirmed low folate or high homocysteine levels.

Cardiovascular Risk

Elevated homocysteine is an established independent risk factor for atherosclerosis, coronary artery disease, stroke, and venous thromboembolism. The TT genotype is consistently associated with higher homocysteine levels, especially in populations with low folate intake. However, it is important to note that homocysteine is just one of many cardiovascular risk factors. Having the TT genotype does not mean you will develop heart disease — it means monitoring and optimizing your homocysteine through adequate folate, B12, and B6 intake is worth doing. A simple blood test can measure your homocysteine level and confirm whether intervention is needed.

What to Do If You Carry the MTHFR C677T Variant

If you discover you carry one or two copies of the C677T variant, here are evidence-based steps:

1Prioritize Folate-Rich Foods

Dark leafy greens (spinach, kale, collard greens), lentils, chickpeas, asparagus, broccoli, and avocado are all excellent natural folate sources. Unlike folic acid, dietary folate is already partially in forms your body can use without full MTHFR conversion.

2Consider Methylfolate Over Folic Acid

If you supplement, look for L-methylfolate (5-MTHF) rather than standard folic acid. Methylfolate is the already-active form and does not require MTHFR to convert it. This is particularly relevant for TT homozygous individuals. Standard doses of 400–800 mcg are typical; discuss higher doses with a healthcare provider.

3Support the Full B-Vitamin Chain

Folate does not work in isolation. Vitamin B12 (as methylcobalamin) is needed alongside 5-MTHF to complete the homocysteine-to-methionine conversion. Vitamin B6 supports an alternative homocysteine clearance pathway. Ensuring adequate intake of all three B vitamins is more important than focusing on folate alone.

4Test Your Homocysteine Level

Rather than guessing, ask your doctor for a serum homocysteine test. Normal levels are generally below 12 μmol/L, with optimal levels often cited below 8 μmol/L. If your homocysteine is normal, your current diet and supplementation are likely adequate regardless of your genotype. If elevated, targeted B-vitamin supplementation can usually bring it down.

5Do Not Panic

Carrying an MTHFR variant is extremely common. Most carriers live completely healthy lives without ever knowing their genotype. The value of knowing is that it gives you actionable information — you can optimize your nutrition proactively rather than reactively. It is not a diagnosis and it is not a disease.

How Common Is MTHFR C677T?

The C677T variant is found across all human populations, though frequencies vary by ancestry:

PopulationCT FrequencyTT Frequency
European~40%~10-12%
Hispanic / Latino~35%~15-25%
East Asian~35%~8-12%
South Asian~25-30%~5-8%
African~15-20%~1-3%

Sources: Wilcken et al. (2003), J. Med. Genet.; Leclerc et al. (2013), Hum. Mutat. Frequencies are approximate and vary within populations.

Methylfolate vs. Folic Acid: Which Should You Take?

This is the most common practical question MTHFR carriers have. Here is the distinction:

Folic acidis the synthetic form of folate found in most supplements and fortified foods. It must be converted through several enzymatic steps — including one catalyzed by MTHFR — to become the active 5-MTHF form. If your MTHFR enzyme is less efficient, this conversion may be slower, and unmetabolized folic acid can accumulate in your blood.

L-Methylfolate (5-MTHF) is the biologically active form that bypasses the MTHFR step entirely. It goes directly into the folate cycle without needing enzymatic conversion. For MTHFR carriers — particularly those with the TT genotype — methylfolate is generally the better supplemental form.

That said, folic acid is not harmful for most CT heterozygous individuals, and the fortification of food with folic acid has dramatically reduced neural tube defects worldwide. The nuance matters: if you are TT homozygous and trying to optimize, methylfolate is the better choice. If you are CT heterozygous and eating a balanced diet with adequate folate, you likely do not need to make any changes.

Know Your Status

Your MTHFR Status Is One of 3,550+ Markers in Your Helix Report

Helix Sequencing analyzes your existing DNA file (from 23andMe, AncestryDNA, or any genotyping chip) and checks your MTHFR C677T and A1298C status alongside thousands of other clinically relevant genetic markers — including polygenic risk scores for cardiovascular disease, mental health conditions, and nutritional needs. Processed in minutes, deleted immediately.

Upload Your DNA File

Get Your Full Genetic Analysis

Upload your existing DNA file from 23andMe, AncestryDNA, or MyHeritage. Get 3,550+ polygenic risk scores, pharmacogenomics for 34 genes, and an AI-generated longevity protocol. Connect your genome to Claude or ChatGPT.

Analyze My DNA